Pucci Paolo
Insider CIK 1436861 · ARQL Chief Executive Officer, Director · WST Director · (NLNK) Director · TRIL Director · MRUS Director · REPL Director · DYAX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2026-05-04 | 2026-05-06 | 791 | — | $0 | 11,854 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2026-04-01 | 2026-04-07 | 44,500 | — | $0 | 44,500 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 13,193 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 8,844 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 14,414 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 16,604 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 17,262 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | D To issuer deriv | 2025-12-12 | 2025-12-12 | 6,120 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2025-05-22 | 2025-05-27 | 13,193 | — | $0 | 13,193 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2025-05-06 | 2025-05-08 | 1,071 | — | $0 | 10,947 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2025-04-01 | 2025-04-03 | 32,000 | — | $0 | 32,000 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2024-05-07 | 2024-05-09 | 8,844 | — | $0 | 8,844 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2024-04-23 | 2024-04-25 | 564 | — | $0 | 9,876 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2024-04-01 | 2024-04-03 | 32,000 | — | $0 | 32,000 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2023-06-08 | 2023-06-12 | 14,414 | — | $0 | 14,414 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2023-04-25 | 2023-04-27 | 616 | — | $0 | 9,312 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2023-04-01 | 2023-04-04 | 25,200 | — | $0 | 25,200 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2022-05-31 | 2022-06-02 | 16,604 | — | $0 | 16,604 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2022-05-24 | 2022-05-26 | 632 | — | $0 | 8,696 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2022-04-01 | 2022-04-05 | 16,500 | — | $0 | 16,500 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 67,000 | — | $0 | 0 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2021-05-28 | 2021-06-02 | 6,120 | — | $0 | 6,120 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2021-05-04 | 2021-05-06 | 577 | — | $0 | 8,064 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2021-04-01 | 2021-04-05 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MRUS Merus N.V. | A Award deriv | 2020-06-30 | 2020-07-02 | 17,262 | — | $0 | 17,262 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2020-05-05 | 2020-05-07 | 975 | — | $0 | 7,470 | SEC↗ |
| REPL Replimune Group, Inc. | A Award deriv | 2020-04-01 | 2020-04-02 | 33,000 | — | $0 | 33,000 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 120,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 242,502 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 300,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 600,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 249,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 80,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 150,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 650,850 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 100,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 14,925 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 305,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 285,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | D To issuer deriv | 2020-01-16 | 2020-01-16 | 7,578 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | U Tender | 2020-01-16 | 2020-01-16 | 1,235,782 | $20.00 | $24.72M | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-12-18 | 2019-12-20 | 225,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-12-18 | 2019-12-20 | 302,422 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-12-18 | 2019-12-20 | 285,075 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-12-18 | 2019-12-20 | 360,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2019-12-18 | 2019-12-20 | 646,639 | $20.11 | $13.00M | 1,235,245 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-12-18 | 2019-12-20 | 360,000 | $1.79 | $644.4K | 1,881,884 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-12-18 | 2019-12-20 | 285,075 | $6.70 | $1.91M | 1,521,884 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-12-18 | 2019-12-20 | 302,422 | $7.95 | $2.40M | 1,236,809 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-12-18 | 2019-12-20 | 225,000 | $3.42 | $769.5K | 934,387 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-09-11 | 2019-09-12 | 5,000 | — | $0 | 7,578 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-09-11 | 2019-09-12 | 5,000 | $7.95 | $39.8K | 707,417 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2019-05-07 | 2019-05-09 | 1,565 | — | $0 | 6,367 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2019-03-15 | 2019-03-18 | 50,000 | — | $0 | 242,502 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2019-03-15 | 2019-03-18 | 50,000 | $1.16 | $58.0K | 618,208 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2019-03-12 | 2019-03-14 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2019-01-15 | 2019-01-17 | 650,850 | — | $0 | 650,850 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2018-07-23 | 2018-07-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2018-06-08 | 2018-06-11 | 101,264 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2018-06-08 | 2018-06-11 | 398,736 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2018-06-08 | 2018-06-11 | 101,264 | $3.95 | $400.0K | 521,758 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2018-06-08 | 2018-06-11 | 398,736 | $3.95 | $1.58M | 920,494 | SEC↗ |
| ARQL ARQULE INC | F Tax w/h | 2018-06-08 | 2018-06-11 | 352,286 | $5.78 | $2.04M | 568,208 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2018-05-23 | 2018-05-25 | 27,777 | — | $0 | 27,777 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2018-05-18 | 2018-05-18 | 15,000 | $3.39 | $50.9K | 420,494 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2018-05-10 | 2018-05-11 | 1,300 | $2.64 | $3.4K | 405,494 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2018-05-08 | 2018-05-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2018-05-01 | 2018-05-03 | 1,824 | — | $0 | 4,802 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2018-01-16 | 2018-05-10 | 249,000 | — | $0 | 249,000 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2017-09-07 | 2017-09-08 | 1,101 | $1.15 | $1.3K | 404,194 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2017-09-06 | 2017-09-07 | 16,397 | $1.15 | $18.9K | 403,093 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2017-09-05 | 2017-09-06 | 19,156 | $1.14 | $21.8K | 386,696 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2017-08-29 | 2017-08-31 | 300 | $1.05 | $315 | 367,540 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2017-08-28 | 2017-08-29 | 2,970 | $1.05 | $3.1K | 367,240 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2017-08-25 | 2017-08-28 | 701 | $1.05 | $736 | 364,270 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2017-08-24 | 2017-08-28 | 8,791 | $1.05 | $9.2K | 363,569 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2017-05-12 | 2017-05-16 | 13,309 | — | $0 | 13,309 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2017-05-02 | 2017-05-03 | 1,697 | — | $0 | 2,978 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2017-01-17 | 2017-01-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award deriv | 2016-09-30 | 2016-10-04 | 56 | $74.12 | $4.2K | 56 | SEC↗ |
| WST WEST PHARMACEUTICAL SERVIC | A Award | 2016-09-12 | 2016-09-13 | 1,277 | — | $0 | 1,277 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2016-08-09 | 2016-08-11 | 17,773 | — | $0 | 17,773 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2016-08-09 | 2016-08-11 | 4,783 | — | $0 | 4,783 | SEC↗ |
| ARQL ARQULE INC | M Exercise deriv | 2016-03-03 | 2016-03-04 | 97,498 | — | $0 | 292,502 | SEC↗ |
| ARQL ARQULE INC | M Exercise | 2016-03-03 | 2016-03-04 | 97,498 | $1.16 | $113.1K | 354,778 | SEC↗ |
| DYAX DYAX CORP | D To issuer deriv | 2016-01-22 | 2016-01-22 | 50,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | D To issuer | 2016-01-22 | 2016-01-22 | 80,000 | — | $0 | 0 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2016-01-19 | 2016-01-20 | 480,000 | — | $0 | 480,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2016-01-13 | 2016-01-15 | 75,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2016-01-13 | 2016-01-15 | 75,000 | $1.51 | $113.3K | 80,000 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2015-12-15 | 2015-12-16 | 1,283 | $2.16 | $2.8K | 257,280 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2015-12-11 | 2015-12-14 | 1,108 | $2.10 | $2.3K | 255,997 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2015-12-10 | 2015-12-11 | 6,600 | $2.10 | $13.9K | 254,889 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2015-12-09 | 2015-12-11 | 1,009 | $2.10 | $2.1K | 248,289 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2015-05-12 | 2015-05-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2015-01-20 | 2015-01-21 | 390,000 | — | $0 | 390,000 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2014-11-20 | 2014-11-20 | 5,000 | $1.26 | $6.3K | 247,280 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2014-09-04 | 2014-09-05 | 5,000 | $1.31 | $6.5K | 242,280 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2014-05-23 | 2014-05-27 | 5,000 | $1.40 | $7.0K | 237,280 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2014-05-20 | 2014-05-21 | 5,000 | $1.42 | $7.1K | 232,280 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2014-03-13 | 2014-03-14 | 10,000 | $2.10 | $21.0K | 227,280 | SEC↗ |
| DYAX DYAX CORP | M Exercise deriv | 2014-03-05 | 2014-03-06 | 25,000 | — | $0 | 0 | SEC↗ |
| DYAX DYAX CORP | S Sale | 2014-03-05 | 2014-03-06 | 20,000 | $10.31 | $206.2K | 5,000 | SEC↗ |
| DYAX DYAX CORP | M Exercise | 2014-03-05 | 2014-03-06 | 25,000 | $1.35 | $33.8K | 25,000 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2014-01-22 | 2014-01-24 | 305,000 | — | $0 | 305,000 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2013-01-14 | 2013-01-15 | 285,000 | — | $0 | 1,725,000 | SEC↗ |
| ARQL ARQULE INC | P Buy | 2012-06-06 | 2012-06-07 | 4,754 | $6.24 | $29.7K | 217,280 | SEC↗ |
| DYAX DYAX CORP | A Award deriv | 2012-05-09 | 2012-05-11 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ARQL ARQULE INC | A Award deriv | 2012-02-01 | 2012-02-03 | 315,000 | — | $0 | 1,440,000 | SEC↗ |